Skip to main content
Research and innovation
News article14 September 2020Directorate-General for Research and Innovation

MedTech Open Innovation Testbed open call for SMEs tackling covid-19

Small and Medium-sized Enterprises (SMEs) and other business were put at high risk by the economic slowdown caused by the COVID-19 pandemic across Europe. Consequently, the three EU funded MedTech Open Innovation Testbed (OITB) projects TBMED, MDOT and SAFE-N-MEDTECH decided to work together to provide services to selected innovators and help them reach the market faster. The three OITB projects have allocated part of their budgets to include new case studies in their on-going projects. Innovative SMEs, companies, start-ups and applied research institutions working on the development of solutions to fight the virus are invited to apply to this call.


The concept of OITBs to forge pan-European innovation networks tailored to the specific needs of novel medical technologies makes them the ideal instruments for quickly finding solutions under urgent conditions such as the COVID-19 outbreak.

The three OITBs thus initiate a call for expressions of interest from MedTech SMEs performing COVID-19-related developments. Support will be provided in the following ways:

  • TBMED offers services to developers from the high-risk medical devices sector, particularly with regard to characterisation, prevention, diagnosis, treatment, follow-up and the forecast of patient prognosis related to COVID-19. Such services include, among others, early dialogues with the Basque HTA office, expert advice for regional and/or multinational clinical trials on COVID-19 and the assessment of needs of such companies regarding clinical trials.
  • MDOT members who develop routines and processes to accelerate the conformity assessment of medical devices, offer consultation regarding regulatory affairs and technology development in the fields of inhalation technologies and environmental sensors.
  • SAFE-N-MEDTECH with its key expertise in nano-enabled medical technologies, offers characterization, preclinical validation, access to biobanks and patient samples, scale up and regulatory support, technology assessment and horizon scanning.

More information

Coronavirus research and innovation

Key enabling technologies: Advanced materials


Publication date
14 September 2020
Directorate-General for Research and Innovation